Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.

    Employee engagement program overview
    ICON and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Obesity 2025 insights image
    Obesity

    A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

    Biological research visual element
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    banners
    From bottlenecks to breakthroughs

    Human-centred strategies for faster study starts

    More than monitoring whitepaper
    More than monitoring

    How modern monitoring paradigms impact CRA roles

    digital globe network with icons
    Meeting requirements for Joint Clinical Assessments

    A planning guide for health technology developers

  • News & Events
    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media
    webinar
    Best practices in global flow cytometry quality control and harmonisation

    5 March 2026. Register today.

    webinar
    When patients lead: Breaking barriers in ultra-rare disease drug development

    3 March 2026. Register today.

  • About ICON
    About ICON
    Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality
    ICON for
    Patients Volunteers Investigators Jobs & Careers Investors Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    ICON Cares is our commitment to making a positive impact on our people, environment and our community.

    Modern reception area at Dublin office
    ICON at a glance

    Delivering successful outcomes across the clinical development lifecycle.

  • Careers
  • Investors
  • Contact
  • 日本語
  • 简体中文
  1. Home
  2. News & Events
  3. Social media

Social media

Page tools
Share Share
Facebook

Share on Facebook

Facebook

Share on X

Facebook

Share on Linkedin

Bluesky

Share on Bluesky

Showing 49 - 60 of 955 results for "*"

Social media image
ICON Plc logo
ICON Plc

ICON provides comprehensive cardiac safety monitoring supported by a team of cardiovascular electrophysiology specialists, board certified cardiologists, radiologists, and medical experts. We offer protocol consulting,...

13 Feb
Social media image
ICON Plc logo
ICON Plc

Looking forward to #ASCPT2026. Come along to the ICON partner hub for a chat and don’t miss our Learning Lab session on 5th March at 10:30 where we will be discussing considerations for the design, safety, pharmacokineti...

12 Feb
Social media image
ICON Plc logo
ICON Plc

Latest issue out now. Keep up to date on the most recent regulatory changes in the world of pharma, biotech and medical device clinical trials with ICON’s Regulatory Intelligence Newsletter. Join thousands of subscribe...

12 Feb
ICON Plc facebook post
ICON Plc logo
ICON Plc

Latest issue out now. Keep up to date on the latest changes with ICON’s Regulatory Intelligence Newsletter. Join thousands of subscribers who have discovered the convenience of this free monthly publication by signing ...

12 Feb
2
Social media image
ICON Plc logo
ICON Plc

ICON’s Patient Centred Outcomes and the American Academy of Sleep Medicine have developed PLATO 11, a validated, patient centred PRO tool designed to better capture the lived experience of people with obstructive sleep a...

12 Feb
ICON Plc facebook post
ICON Plc logo
ICON Plc

ICON’s Patient Centred Outcomes and the American Academy of Sleep Medicine have developed PLATO 11, a validated, patient centred PRO tool designed to better capture the lived experience of people with obstructive sleep a...

12 Feb
2
Social media image
ICON Plc logo
ICON Plc

When patients lead, progress follows. Join ICON’s Centre for Rare Diseases for a special Rare Disease Day webinar exploring how patient and parent leaders are breaking barriers in ultra rare disease drug development. F...

12 Feb
ICON Plc facebook post
ICON Plc logo
ICON Plc

In recognition of Rare Disease Day, join ICON’s Centre for Rare Diseases for an inspiring webinar featuring patient and parent leaders and experts who are helping to accelerate treatments for ultra rare diseases. Registe...

12 Feb
3
ICON Plc facebook post
ICON Plc logo
ICON Plc

AI is helping transform how clinicians diagnose, treat, and support patients — but not without challenges. One of the biggest? Biases inside the algorithms. Our new blog explains how AI used in software as a medical dev...

12 Feb
2
Social media image
ICON Plc logo
ICON Plc

Managing AI model biases in SaMD is no longer optional - it’s essential. As AI enabled medical devices accelerate through FDA authorisation, developers must ensure their models don’t unintentionally reinforce healthcare ...

12 Feb
Social media image
ICON Plc logo
ICON Plc

Artificial intelligence is transforming how life sciences teams plan, execute, and scale commercial strategy—but the true differentiator isn’t the algorithm. It’s the data foundation behind it. In our latest blog, we ex...

11 Feb
ICON Plc facebook post
ICON Plc logo
ICON Plc

AI is changing the way life sciences organisations work—but strong data foundations are what make AI truly effective. In our new blog, Symphony Health, an ICON plc company, breaks down what it means for healthcare data ...

11 Feb
1
  • Previous
  • 1
  • …
  • 4
  • 5
  • 6
  • …
  • 80
  • Next
Filter by:

Filter by:

Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Content preferences
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
Socials
  • Linkedin
  • Facebook
  • Instagram
  • Youtube

Legal Footer

  • © 2026 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies
How can we help?
  • All
  • Website
Popular search terms:
  • Biotech
  • Cell and Gene Therapies
  • Consulting
  • Early Clinical
  • Medical Device
  • Oncology
  • Rare & Orphan Diseases
  • Real World Evidence
  • Site & Patient Recruitment
  • Strategic Solutions
  • Regulatory Intelligence